Friday, March 18, 2022 12:07:36 PM
(a) On March 16, 2022, Cardiff Lexington Corp. (the “Company”) dismissed Rosenberg Rich Baker Berman PA (“RRBB”) as the Company’s independent registered public accounting firm.
RRBB was engaged as the Company’s independent registered public accounting firm on or about June 23, 2021. As described in the Company’s Form 12b-25s filed with the Securities and Exchange Commission (the “Commission”) on August 24, 2021 and November 12, 2021 relating, respectively, to the Company’s Quarterly Reports on Form 10-Q for the quarters ended June 30, 2021 and September 30, 2021, which are incorporated herein by reference, RRBB was unable to complete its review of the Company’s June 30, 2021 and September 30, 2021 financial statements as they were evaluating issues that they believed could result in material errors in the Company’s financial statements for the years ended December 31, 2019 and December 31, 2020, and within the interim periods within those fiscal years.
Working with the Company’s prior auditors as well as outside consultants, the Company concluded that its previously issued consolidated financial statements as of and for the year ended December 31, 2020 included in our Annual Report on Form 10-K (the “2020 10-K”) and the Company’s unaudited condensed consolidated financial statements for the three months ended and 2021 year-to-date period ended March 31, 2021 (the “2021 Q-1 10-Q”) should no longer be relied upon. Reference is made to the Company’s Current Report on Form 8-K filed with the Commission on February 17, 2022 to that effect, which is incorporated herein by this reference. should no longer be relied upon. Amendments to the 2021 10-K and the 2021 Q-1 10-Q (collectively, the “Amendments”) were filed on February 18, 2022.
After filing the Amendments, the Company, on February 21, 2022, furnished information to RRBB in order to begin the process of obtaining a review of the Quarterly Reports on Form 10-Q for the quarters ended June 30, 2020 and September 30, 2021. At that time, the Company was advised that “[a]t this point, we don’t have the capacity to get back into procedures over the revised financial information you provided. We expect to begin our procedures during the first week of April 2022, however if that changes, we will let you know.” The Company was further advised that “prior to beginning any audit procedures on the company’s financial statements for the year ended December 31, 2021, we need to complete the reviews of the June 30th and September 30th financial statements for filing of the 10Q’s.”
Accordingly, the decision was made to dismiss RRBB. This decision was made by the Company’s board of directors.
As indicated above, RRBB never issued a report on the Company’s financial statements for the fiscal years ended December 31, 2021 and 2020 – as a result, there was no adverse opinion or a disclaimer of opinion and there was no opinion that was qualified or modified as to uncertainty, audit scope, or accounting principles.
Furthermore, from June 23, 2021 to the present, there were no disagreements with RRBB on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to RRBB’s satisfaction, would have caused RRBB to make reference to the subject matter of the disagreement in connection with its reports on the Company’s financial statements for such periods.
From June 23, 2021 to the present, there we no “reportable events” as that term is described in Item 304(a)(1)(v) of Regulation S-K.
The Company has provided RRBB with a copy of the disclosure contained herein, prior to its filing with the Securities and Exchange Commission (the “Commission”), and requested that RRBB furnish the Company a letter addressed to the Commission stating whether or not it agreed with the statements herein and, if not, stating the respects in which it does not agree. RRBB’s letter to the Commission is attached hereto as Exhibit 16.1.
(b) On March 16, 2021, the Board of Directors approved the appointment of Grassi & Co., CPAs, P.C. (“Grassi”) as the Company’s independent registered public accounting firm. During the Company’s two most recent fiscal years through March 16, 2022, neither the Company nor anyone acting on the Company’s behalf consulted Grassi with respect to any of the matters or reportable events set forth in Item 304(a)(2)(i) and (ii) of Regulation S-K.
Item 9.01. Financial Statements and Exhibits.
Recent CDIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:50:17 PM
- Form DEFR14C - Revised information statement materials, definitive • Edgar (US Regulatory) • 11/29/2023 03:18:50 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/16/2023 09:11:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 07:06:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:29:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/25/2023 07:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 07:56:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 05:25:09 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/03/2023 08:51:51 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/19/2023 09:02:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/29/2023 08:04:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM